Skip to main content

Strata Critical Medical, Inc 10-Q for FY2026 Q3

Strata Critical Medical, Inc. (SRTA)

10-Q 2026-11-03 For: 2026-09-30
View Original
Added on November 03, 2026

About this 10-Q

Strata Critical Medical, Inc filed this 10-Q on November 3, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).

Strata Critical Medical reported three-month revenue of $74.1 million, up 50.3% from $49.3 million, and gross margin of 22.7% versus 21.6%; net loss from continuing operations was $7,615 thousand. AI summary

Headline figures

Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$74.08M
up 50.3% from $49.3M a year earlier
Net loss
$7.62M
compared with net income of $57.42M a year earlier
Diluted EPS
-$0.09
compared with $0.70 a year earlier